How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists.
Most of us did not even know what they were – natural hormones that regulate appetite, helping to reduce hunger and calorie intake.
Today, GLP-1 drugs like semaglutide and tirzepatide are prescribed in their thousands and have altered global health.
This pharmaceutical success has sparked an intense obsession, triggering aggressive online marketing for “skinny pens” – self-injectable pens containing the medication.
Since April,...
Obesity drugs linked to stalling cancer
- Weight-loss drugs from Lilly, Novo linked to stalling cancer: report Seeking Alpha —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —
- New weight-loss drug Retatrutide showing stronger results than current options CBS News —
- Experimental drug yields dramatic weight loss Boston Globe —
- Dr. Alok Patel breaks down Ebola concerns and new weight loss drug 📹 ABC News — · 1min